Both of the tested dual agonists DA-CH5 and DA-JC4, were able to normalize glucose intolerance and glucose-stimulated secretory response in symptomatic 5-month-old Wfs1 KO rats. The gene discussed is WFS1; the disease is Glucose intolerance.